Centipeda minima is a Chinese herbal medicine used in the treatment of various diseases including cancer. An ethanol extract of the herb, its four fractions with different polarities, and two volatile oils prepared by steam distillation (SD) and supercritical fluid extraction (SFE) were investigated for their anti-angiogenic activity in a wild-type zebrafish model using a quantitative endogenous alkaline phosphatase (EAP) assay. The SFE oil displayed potent anti-angiogenic activity. Fifteen sesquiterpene lactones (SLs; compounds 1–15) isolated from the SFE oil were evaluated for their anti-angiogenic effect. Results revealed that pseudoguaianolide type SLs (1–8) inhibited vessel formation in the zebrafish embryos while guaianolide type SLs (9–15) showed little effect. Among the active ones, 6-O-angeloylenolin (1), a major component of SFE oil, possessed the strongest effect by reducing vessel formation in zebrafish embryos to 40% of the control value at 29.7 μM. Further study using the Tg (fli1a:EGFP) y1-type zebrafish model revealed that it blocked both intersegmental blood vessels (ISVs) and subintestinal vessels plexus (SIVs) formation in zebrafish embryos. Real-time polymerase chain reaction assay on the wild-type zebrafish embryos suggested that 6-O-angeloylenolin affected multiple molecular targets related to angiogenesis including VEGF receptor, angiopoietin, and its receptors. Taken together, our findings demonstrate that C. minima possesses anti-angiogenic activity, and 6-O-angeloylenolin is a promising candidate for the development of an anti-angiogenic agent.
FolkmanJ. (1995) Angiogenesis in cancer, vascular, rheumatoid and other disease. Nature Medicine, 1, 27–31.
2.
PapettiM., HermanI.M. (2002) Mechanisms of normal and tumor-derived angiogenesis. American Journal of Physiology and Cell Physiology, 282, 947–970.
3.
HurwitzH., FehrenbacherL., NovotnyW., CartwrightT., HainsworthJ., HeimW., BerlinJ., BaronA., GriffingS., HolmgrenE. (2004) Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer. New England Journal of Medicine, 350, 2335–2342; (b) Miller KD, Chap LI, Holmes FA, Cobleigh MA, Marcom PK, Fehrenbacher L, Dickler M, Overmoyer BA, Reimann JD, Sing AP. (2005) Randomized phase III trial of capecitabine compared with bevacizumab plus capecitabine in patients with previously treated metastatic breast cancer. Journal of Clinical Oncology, 23, 792–799; (c) Sandler A, Gray R, Perry MC, Brahmer J, Schiller JH, Dowlati A, Lilenbaum R, Johnson DH. (2006) Paclitaxel-carboplatin alone or with bevacizumab for non-small-cell lung cancer. New England Journal of Medicine, 355, 2542–2550; (d) Patard JJ, Pignot G, Escudier B, Eisen T, Bex A, Sternberg C, Rini B, Roigas J, Choueiri T, Bukowski R. (2011) ICUD-EAU international consultation on kidney cancer 2010: treatment of metastatic disease. European Urology, 60, 684–690.
4.
Editorial Committee of Pharmacopoeia. (2005) Pharmacopoeia of China.Beijing, 241–242.
5.
HuangS.S., ChiuC.S., LinT.H., LeeM.M., LeeC.Y., ChangS.J., HouW.C., HuangG.J., DengJ.S. (2013) Antioxidant and anti-inflammatory activities of aqueous extract of Centipeda minima. Journal of Ethnopharmacology, 147, 395–405; (b) Liang H, Bao F, Dong X, Tan R, Zhang C, Lu Q, Cheng Y. (2007) Antibacterial thymol derivatives isolated from Centipeda minima. Molecules, 12, 1606–1613; (c) Su M, Wu P, Li Y, Chung HY. (2010) Antiproliferative effects of volatile oils from Centipeda minima on human nasopharyngeal cancer CNE cells. Natural Product Communications, 5, 151–156; (d) Su M, Li Y, Chung HY, Ye W. (2009) 2β-(Isobutyryloxy)florilenalin, a sesquiterpene lactone isolated from the medicinal plant Centipeda minima, induces apoptosis in human nasopharyngeal carcinoma CNE cells. Molecules, 14, 2135–2146.
6.
WuP., LiX.G., LiangN., WangG.C., YeW.C., ZhouG.X., LiY.L. (2012) Two new sesquiterpene lactones from the supercritical fluid extract of Centipeda minima. Journal of Asian Natural Products Research, 14, 515–520; (b) Wu P, Su MX, Wang Y, Wang GC, Ye WC, Chung HY, Li J, Jiang RW, Li YL. (2012) Supercritical fluid extraction assisted isolation of sesquiterpene lactones with antiproliferative effects from Centipeda minima. Phytochemistry, 76, 133–140; (c) Su M, Chung HY, Li Y. (2011) 6-O-Angeloylenolin induced cell-cycle arrest and apoptosis in human nasopharyngeal cancer cells. Chemico-Biological Interactions, 189, 167–176; (d) Liu Y, Chen XQ, Liang HX, Zhang FX, Zhang B, Jin J, Chen YL, Cheng YX, Zhou GB. (2011) Small compound 6-O-angeloylplenolin induces mitotic arrest and exhibits therapeutic potentials in multiple myeloma. PLoS one, 6, e21930; (e) Changlong L, Hezhen W, Yongping H, Yanfang Y, Yanwen L, Jianwen L. (2008) 6-O-Angeloylenolin induces apoptosis through a mitochondrial/caspase and NF-kappaB pathway in human leukemia HL60 cells. Biomedicine & Pharmacotherapy, 62, 401–409.
ThomasM., AugustinH.G. (2009) The role of the angiopoietins in vascular morphogenesis. Angiogenesis, 12, 125–137.
9.
FerraraN., GerberH.P., Le CouterJ. (2003) The biology of VEGF and its receptors. Nature Medicine, 9, 669–676.
10.
HoffP.M., WolffR.A., BogaardK., WaldrumS., AbbruzzeseJ.L. (2006) A Phase I study of escalating doses of the tyrosine kinase inhibitor semaxanib (SU5416) in combination with irinotecan in patients with advanced colorectal carcinoma. Japanese Journal of Clinical Oncology, 36, 100–103.
11.
HeZ.H., YueG.G.L., LauC.B.S., GeW., ButP.P.H. (2012) Antiangiogenic effects and mechanisms of trans-ethyl p-methoxycinnamate from Kaempferia galanga L. Journal of Agricultural and Food Chemistry, 60, 11309–11317.
12.
HeZ.H., ZhouR., HeM.F., LauC.B.S., YueG.G.L., GeW., ButP.P.H. (2011) Anti-angiogenic effect and mechanism of rhein from Rhizoma Rhei. Phytomedicine, 18, 470–478.
